Report Detail
Global Influenza Vaccination Market Professional Survey Report 2019
- RnM3799308 |
- 02 October, 2019 |
- Global |
- 104 Pages |
- QYResearch |
- Pharma & Healthcare
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
The global Influenza Vaccination market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Influenza Vaccination volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenza Vaccination market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Influenza Vaccination in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Influenza Vaccination manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott (US)
AstraZeneca (Europe)
BioCryst Pharmaceuticals, Inc. (US)
Novartis AG (Europe)
DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
GlaxoSmithKline plc. (Europe)
Hualan Biological Engineering Inc (Asia Pacific)
Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
F. Hoffmann-La Roche Ltd (Europe)
Sanofi (Europe)
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
by Technology
Egg Based
Cell Culture
Recombinant
by Vaccines
Fluzone
Flumist
Fluvirin
Fluvax
Segment by Application
Hospitals
Research Organizations
Table of Contents
Executive Summary
1 Industry Overview of Influenza Vaccination
- 1.1 Definition of Influenza Vaccination
- 1.2 Influenza Vaccination Segment by Technology
- 1.2.1 Global Influenza Vaccination Production Growth Rate Comparison by Technology (2014-2025)
- 1.2.2 Egg Based
- 1.2.3 Cell Culture
- 1.2.4 Recombinant
- 1.3 Influenza Vaccination Segment by Applications
- 1.3.1 Global Influenza Vaccination Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Research Organizations
- 1.4 Global Influenza Vaccination Overall Market
- 1.4.1 Global Influenza Vaccination Revenue (2014-2025)
- 1.4.2 Global Influenza Vaccination Production (2014-2025)
- 1.4.3 North America Influenza Vaccination Status and Prospect (2014-2025)
- 1.4.4 Europe Influenza Vaccination Status and Prospect (2014-2025)
- 1.4.5 China Influenza Vaccination Status and Prospect (2014-2025)
- 1.4.6 Japan Influenza Vaccination Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Influenza Vaccination Status and Prospect (2014-2025)
- 1.4.8 India Influenza Vaccination Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Influenza Vaccination
- 2.3 Manufacturing Process Analysis of Influenza Vaccination
- 2.4 Industry Chain Structure of Influenza Vaccination
3 Development and Manufacturing Plants Analysis of Influenza Vaccination
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Influenza Vaccination Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Influenza Vaccination
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Influenza Vaccination Production and Capacity Analysis
- 4.2 Influenza Vaccination Revenue Analysis
- 4.3 Influenza Vaccination Price Analysis
- 4.4 Market Concentration Degree
5 Influenza Vaccination Regional Market Analysis
- 5.1 Influenza Vaccination Production by Regions
- 5.1.1 Global Influenza Vaccination Production by Regions
- 5.1.2 Global Influenza Vaccination Revenue by Regions
- 5.2 Influenza Vaccination Consumption by Regions
- 5.3 North America Influenza Vaccination Market Analysis
- 5.3.1 North America Influenza Vaccination Production
- 5.3.2 North America Influenza Vaccination Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Influenza Vaccination Import and Export
- 5.4 Europe Influenza Vaccination Market Analysis
- 5.4.1 Europe Influenza Vaccination Production
- 5.4.2 Europe Influenza Vaccination Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Influenza Vaccination Import and Export
- 5.5 China Influenza Vaccination Market Analysis
- 5.5.1 China Influenza Vaccination Production
- 5.5.2 China Influenza Vaccination Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Influenza Vaccination Import and Export
- 5.6 Japan Influenza Vaccination Market Analysis
- 5.6.1 Japan Influenza Vaccination Production
- 5.6.2 Japan Influenza Vaccination Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Influenza Vaccination Import and Export
- 5.7 Southeast Asia Influenza Vaccination Market Analysis
- 5.7.1 Southeast Asia Influenza Vaccination Production
- 5.7.2 Southeast Asia Influenza Vaccination Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Influenza Vaccination Import and Export
- 5.8 India Influenza Vaccination Market Analysis
- 5.8.1 India Influenza Vaccination Production
- 5.8.2 India Influenza Vaccination Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Influenza Vaccination Import and Export
6 Influenza Vaccination Segment Market Analysis (by Type)
- 6.1 Global Influenza Vaccination Production by Type
- 6.2 Global Influenza Vaccination Revenue by Type
- 6.3 Influenza Vaccination Price by Type
7 Influenza Vaccination Segment Market Analysis (by Application)
- 7.1 Global Influenza Vaccination Consumption by Application
- 7.2 Global Influenza Vaccination Consumption Market Share by Application (2014-2019)
8 Influenza Vaccination Major Manufacturers Analysis
- 8.1 Abbott (US)
- 8.1.1 Abbott (US) Influenza Vaccination Production Sites and Area Served
- 8.1.2 Abbott (US) Product Introduction, Application and Specification
- 8.1.3 Abbott (US) Influenza Vaccination Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 AstraZeneca (Europe)
- 8.2.1 AstraZeneca (Europe) Influenza Vaccination Production Sites and Area Served
- 8.2.2 AstraZeneca (Europe) Product Introduction, Application and Specification
- 8.2.3 AstraZeneca (Europe) Influenza Vaccination Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 BioCryst Pharmaceuticals, Inc. (US)
- 8.3.1 BioCryst Pharmaceuticals, Inc. (US) Influenza Vaccination Production Sites and Area Served
- 8.3.2 BioCryst Pharmaceuticals, Inc. (US) Product Introduction, Application and Specification
- 8.3.3 BioCryst Pharmaceuticals, Inc. (US) Influenza Vaccination Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Novartis AG (Europe)
- 8.4.1 Novartis AG (Europe) Influenza Vaccination Production Sites and Area Served
- 8.4.2 Novartis AG (Europe) Product Introduction, Application and Specification
- 8.4.3 Novartis AG (Europe) Influenza Vaccination Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
- 8.5.1 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Production Sites and Area Served
- 8.5.2 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Product Introduction, Application and Specification
- 8.5.3 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 GlaxoSmithKline plc. (Europe)
- 8.6.1 GlaxoSmithKline plc. (Europe) Influenza Vaccination Production Sites and Area Served
- 8.6.2 GlaxoSmithKline plc. (Europe) Product Introduction, Application and Specification
- 8.6.3 GlaxoSmithKline plc. (Europe) Influenza Vaccination Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Hualan Biological Engineering Inc (Asia Pacific)
- 8.7.1 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Production Sites and Area Served
- 8.7.2 Hualan Biological Engineering Inc (Asia Pacific) Product Introduction, Application and Specification
- 8.7.3 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
- 8.8.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Production Sites and Area Served
- 8.8.2 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Product Introduction, Application and Specification
- 8.8.3 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 F. Hoffmann-La Roche Ltd (Europe)
- 8.9.1 F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Production Sites and Area Served
- 8.9.2 F. Hoffmann-La Roche Ltd (Europe) Product Introduction, Application and Specification
- 8.9.3 F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Sanofi (Europe)
- 8.10.1 Sanofi (Europe) Influenza Vaccination Production Sites and Area Served
- 8.10.2 Sanofi (Europe) Product Introduction, Application and Specification
- 8.10.3 Sanofi (Europe) Influenza Vaccination Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Influenza Vaccination Market
- 9.1 Global Influenza Vaccination Market Trend Analysis
- 9.1.1 Global Influenza Vaccination Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Influenza Vaccination Regional Market Trend
- 9.2.1 North America Influenza Vaccination Forecast 2019-2025
- 9.2.2 Europe Influenza Vaccination Forecast 2019-2025
- 9.2.3 China Influenza Vaccination Forecast 2019-2025
- 9.2.4 Japan Influenza Vaccination Forecast 2019-2025
- 9.2.5 Southeast Asia Influenza Vaccination Forecast 2019-2025
- 9.2.6 India Influenza Vaccination Forecast 2019-2025
- 9.3 Influenza Vaccination Market Trend (Product Type)
- 9.4 Influenza Vaccination Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Influenza Vaccination Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Influenza Vaccination. Industry analysis & Market Report on Influenza Vaccination is a syndicated market report, published as Global Influenza Vaccination Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Influenza Vaccination market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
